1. Intravenous Busulfan Plus Melphalan Is a Highly Effective, Well-Tolerated Preparative Regimen for Autologous Stem Cell Transplantation in Patients with Advanced Lymphoid Malignancies 
Partow Kebriaei, Timothy Madden, Reza Kazerooni, Xuemei Wang, Peter F. Thall, Celina Ledesma, Yago Nieto, Elizabeth J. Shpall, Chitra Hosing, Muzaffar Qazilbash, Uday Popat, Issa Khouri, Richard E. Champlin, Roy B. Jones, Borje S. Andersson 
Biology of Blood and Marrow Transplantation 
Volume 17, Issue 3, Pages (March 2011)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Overall survival (OS) and progression-free survival (PFS) for patients with Hodgkin lymphoma. Sensitivity to chemotherapy does not significantly affect outcome.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
OS and PFS for patients with non-Hodgkin lymphoma. Sensitivity to chemotherapy does not have a significant impact on outcome.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 3
OS and PFS for patients with multiple myeloma (MM). Sensitivity to chemotherapy does not significantly affect outcome.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions